ERX-3722

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameERX-3722
Drug Alias NameERX-3722
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatenin beta 1 modulators
TargetsCatenin beta 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEiRx Therapeutics plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEiRx Therapeutics plc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A